Prospective Grant of an Exclusive Patent License: Methods for the Diagnosis and Prognosis of Cancer

Riepilogo

The National Cancer Institute and the National Institute of Arthritis and Musculoskeletal and Skin Diseases, institutes of the National Institutes of Health, Department of Health and Human Services, are contemplating the grant of an Exclusive Patent License to practice the inventions embodied in the patent applications listed in the SUPPLEMENTARY INFORMATION section of this notice to BioncoDx, LLC, a company organized in Delaware.